Invitae Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Invitae's estimated annual revenue is currently $147.7M per year.
- Invitae received $143.8M in venture funding in March 2019.
- Invitae's estimated revenue per employee is $149,644
- Invitae's total funding is $195.5M.
- Invitae has 987 Employees.
- Invitae grew their employee count by 44% last year.
- Invitae currently has 184 job openings.
|Gina Grayum||Regional Director, Gulf Coast West|
|David McManus||Executive Director, Controller|
|Kristin McDonald Gibson||Medical director|
|Nathan McDonald||Medical director|
|Toby Berster||Director Of Engineering|
|Jennifer Roth||Regional Director|
|Robert Werner||Vice President, Corporate Controller|
|Bharadwaj Chivukula||Director Of Engineering/Head of Reliability Engineering|
|Beverly Skram||Area VP, Managed Markets|
|Jody Medveczky||Regional Director, New England|
What Is Invitae?
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world's genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. Choose from our curated panels or design your own test for the same low price. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.keywords:Biotechnology,E-Commerce,Healthcare,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Advanced Cell D...||$25.7M||178||8%||N/A|
|Full Spectrum A...||$6M||42||5%||N/A|
Detect sponsored testing programs are designed to overcome barriers to testing and connect patients to earlier diagnosis and treatments -.
SAN FRANCISCO, Sept. 6, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) announced the pricing on September 5, 2019 of $300.0 ...
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know ... Invitae Corporation (NVTA): Free Stock Analysis Report
|2016-11-18||$44.0M||Undisclosed||J.P. Morgan Securities LLC||Article|
|2018-02-28||$40.0M||Undisclosed||Oxford Finance, LLC||Article|
|2018-03-27||$57.5M||Undisclosed||J.P. Morgan Securities LLC||Article|
|2019-03-05||$143.8M||Undisclosed||J.P. Morgan Securities LLC||Article|
Invitae Executive Hires
|2017-01-09||AltaVoice (formerly PatientCrossroads||Stock Deal -Not Complete||Article|
|2017-08-01||Good Start Genetics, Inc||Article|